Advertisement
ANIP vs PBH
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ANIP is a Hold and PBH is a Hold.
ANIP in downward trend: price dove below 50-day moving average on October 30, 2026
ANIP moved below its 50-day moving average on October 30, 2026 date and that indicates a change from an upward trend to a downward trend. In 36 of 49 similar past instances, the stock price decreased further within the following month. The odds of a continued downward trend are 73%.
Technical Analysis (Indicators)
Bearish Trend Analysis
The Moving Average Convergence Divergence Histogram (MACD) for ANIP turned negative on November 05, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 59 similar instances when the indicator turned negative. In 42 of the 59 cases the stock turned lower in the days that followed. This puts the odds of success at 71%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where ANIP declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 70%.
The Aroon Indicator for ANIP entered a downward trend on October 23, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Bullish Trend Analysis
The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 2 days, which means it's wise to expect a price bounce in the near future.
The Momentum Indicator moved above the 0 level on November 10, 2026. You may want to consider a long position or call options on ANIP as a result. In 69 of 90 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 77%.
Following a +5.70% 3-day Advance, the price is estimated to grow further. Considering data from situations where ANIP advanced for three days, in 213 of 300 cases, the price rose further within the following month. The odds of a continued upward trend are 71%.
ANIP may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Fundamental Analysis (Ratings)
The Tickeron Profit vs. Risk Rating rating for this company is 45 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 83, placing this stock slightly better than average.
The Tickeron SMR rating for this company is 48 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Valuation Rating of 68 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.593) is normal, around the industry mean (6.379). P/E Ratio (13.957) is within average values for comparable stocks, (0.548). Projected Growth (PEG Ratio) (1.856) is also within normal values, averaging (2.202). Dividend Yield (0.000) settles around the average of (0.062) among similar stocks. P/S Ratio (1.657) is also within normal values, averaging (183.387).
The Tickeron Price Growth Rating for this company is 71 (best 1 - 100 worst), indicating slightly worse than average price growth. ANIP’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 96 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
PBH in upward trend: price expected to rise as it breaks its lower Bollinger Band on November 05, 2026
PBH may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In 27 of 40 cases where PBH's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are 68%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 1 day, which means it's wise to expect a price bounce in the near future.
Following a +4.63% 3-day Advance, the price is estimated to grow further. Considering data from situations where PBH advanced for three days, in 172 of 322 cases, the price rose further within the following month. The odds of a continued upward trend are 53%.
The Aroon Indicator entered an Uptrend today. In 118 of 229 cases where PBH Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 52%.
Bearish Trend Analysis
The 10-day RSI Indicator for PBH moved out of overbought territory on November 05, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 32 similar instances where the indicator moved out of overbought territory. In 15 of the 32 cases, the stock moved lower in the following days. This puts the odds of a move lower at 47%.
The Momentum Indicator moved below the 0 level on November 05, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on PBH as a result. In 54 of 85 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 64%.
The Moving Average Convergence Divergence Histogram (MACD) for PBH turned negative on November 05, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 38 similar instances when the indicator turned negative. In 24 of the 38 cases the stock turned lower in the days that followed. This puts the odds of success at 63%.
PBH moved below its 50-day moving average on November 05, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for PBH crossed bearishly below the 50-day moving average on November 06, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 10 of 15 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 67%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where PBH declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 57%.
Fundamental Analysis (Ratings)
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Valuation Rating of 61 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.062) is normal, around the industry mean (6.379). P/E Ratio (12.006) is within average values for comparable stocks, (0.548). Projected Growth (PEG Ratio) (1.482) is also within normal values, averaging (2.202). Dividend Yield (0.000) settles around the average of (0.062) among similar stocks. P/S Ratio (2.042) is also within normal values, averaging (183.387).
The Tickeron PE Growth Rating for this company is 71 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 73 (best 1 - 100 worst), indicating slightly worse than average price growth. PBH’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 74 (best 1 - 100 worst), indicating slightly better than average sales and a considerably profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. PBH’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 83, placing this stock worse than average.
ANIP | PBH | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 60 | 15 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 68 Overvalued | 61 Fair valued | |
PROFIT vs RISK RATING 1..100 | 45 | 100 | |
SMR RATING 1..100 | 48 | 74 | |
PRICE GROWTH RATING 1..100 | 71 | 73 | |
P/E GROWTH RATING 1..100 | 96 | 71 | |
SEASONALITY SCORE 1..100 | 85 | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
PBH's Valuation (61) in the Pharmaceuticals Other industry is in the same range as ANIP (68). This means that PBH’s stock grew similarly to ANIP’s over the last 12 months.
ANIP's Profit vs Risk Rating (45) in the Pharmaceuticals Other industry is somewhat better than the same rating for PBH (100). This means that ANIP’s stock grew somewhat faster than PBH’s over the last 12 months.
ANIP's SMR Rating (48) in the Pharmaceuticals Other industry is in the same range as PBH (74). This means that ANIP’s stock grew similarly to PBH’s over the last 12 months.
ANIP's Price Growth Rating (71) in the Pharmaceuticals Other industry is in the same range as PBH (73). This means that ANIP’s stock grew similarly to PBH’s over the last 12 months.
PBH's P/E Growth Rating (71) in the Pharmaceuticals Other industry is in the same range as ANIP (96). This means that PBH’s stock grew similarly to ANIP’s over the last 12 months.
| ANIP | PBH | |
|---|---|---|
| RSI ODDS (%) | N/A | 2 days ago 47% |
| Stochastic ODDS (%) | 2 days ago 75% | 2 days ago 56% |
| Momentum ODDS (%) | 2 days ago 77% | 2 days ago 64% |
| MACD ODDS (%) | 2 days ago 71% | 2 days ago 63% |
| TrendWeek ODDS (%) | 2 days ago 68% | 2 days ago 59% |
| TrendMonth ODDS (%) | 2 days ago 69% | 2 days ago 57% |
| Advances ODDS (%) | 2 days ago 71% | 2 days ago 53% |
| Declines ODDS (%) | 6 days ago 70% | 6 days ago 57% |
| BollingerBands ODDS (%) | 2 days ago 90% | 2 days ago 68% |
| Aroon ODDS (%) | 2 days ago 71% | 2 days ago 52% |
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
ANIP’s FA Score shows that 0 FA rating(s) are green while PBH’s FA Score has 0 green FA rating(s).
- ANIP’s FA Score: 0 green, 5 red.
- PBH’s FA Score: 0 green, 5 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
ANIP’s TA Score shows that 4 TA indicator(s) are bullish while PBH’s TA Score has 4 bullish TA indicator(s).
- ANIP’s TA Score: 4 bullish, 4 bearish.
- PBH’s TA Score: 4 bullish, 6 bearish.
Price Growth
ANIP (@Pharmaceuticals: Generic) experienced а -1.43% price change this week, while PBH (@Pharmaceuticals: Generic) price change was -9.22% for the same time period.
The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was -0.20%. For the same industry, the average monthly price growth was -6.54%, and the average quarterly price growth was +10.31%.
Reported Earning Dates
ANIP is expected to report earnings on Feb 26, 2027.
PBH is expected to report earnings on Feb 04, 2027.
Industries' Descriptions
@Pharmaceuticals: Generic (-0.20% weekly)A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.
Advertisement
ANIP and
Correlation & Price change
A.I.dvisor indicates that over the last year, ANIP has been loosely correlated with AMRX. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if ANIP jumps, then AMRX could also see price increases.
| Ticker / NAME | Correlation To ANIP | 1D Price Change % | ||
|---|---|---|---|---|
| ANIP | 100% | +5.10% | ||
| AMRX - ANIP | 39% Loosely correlated | +0.47% | ||
| AMPH - ANIP | 33% Loosely correlated | -1.09% | ||
| PBH - ANIP | 32% Poorly correlated | +2.98% | ||
| SNDL - ANIP | 31% Poorly correlated | -0.71% | ||
| COLL - ANIP | 30% Poorly correlated | -0.97% | ||
More | ||||
PBH and
Correlation & Price change
A.I.dvisor indicates that over the last year, PBH has been loosely correlated with ZTS. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if PBH jumps, then ZTS could also see price increases.
| Ticker / NAME | Correlation To PBH | 1D Price Change % | ||
|---|---|---|---|---|
| PBH | 100% | +2.98% | ||
| ZTS - PBH | 36% Loosely correlated | +0.17% | ||
| ANIP - PBH | 31% Poorly correlated | +5.10% | ||
| PRGO - PBH | 30% Poorly correlated | -0.71% | ||
| ELAN - PBH | 29% Poorly correlated | -0.30% | ||
| HLN - PBH | 29% Poorly correlated | +1.00% | ||
More | ||||